{"product_id":"johns-hopkins-wilmer-eye-institutes-3rd-annual-retinal-festival-2022","title":"Johns Hopkins Wilmer Eye Institute’s 3rd Annual Retinal Festival 2022","description":"\u003cdiv\u003e\n\u003cdiv class=\"pnllearningActivityInformationClass\" id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_TopAndSectionDetails_ucLearningActivityInformation_TopAndSectionDetails_rptLearningActivityInformation_pnllearningActivityInformation_0\"\u003e\n\u003cdiv class=\"pnlLearningActivityInformationDescriptionClass\" id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_TopAndSectionDetails_ucLearningActivityInformation_TopAndSectionDetails_rptLearningActivityInformation_pnlLearningActivityInformationDescription_0\"\u003e\n\u003cdiv class=\"pnllearningActivityInformationClass\" id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_TopAndSectionDetails_ucLearningActivityInformation_TopAndSectionDetails_rptLearningActivityInformation_pnllearningActivityInformation_0\"\u003e\n\u003cdiv class=\"pnlLearningActivityInformationDescriptionClass\" id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_TopAndSectionDetails_ucLearningActivityInformation_TopAndSectionDetails_rptLearningActivityInformation_pnlLearningActivityInformationDescription_0\"\u003e\n\u003cdiv\u003e\n\u003ch3\u003eJohns Hopkins Wilmer Eye Institute’s 3rd Annual Retinal Festival 2022\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 9 videos + 21 pdfs, size: 8.03 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eTarget Audience: ophthalmologists, optometrists, and ophthalmic allied health professionals\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eInformation:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003eDate \u0026amp; Location Saturday, December 3, 2022, 7:30 AM – 5:30 PM, Johns Hopkins School of Medicine, Turner Auditorium, Baltimore , MD\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eTarget Audience \u003cem\u003eSpecialties\u003c\/em\u003e – Ophthalmology\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/div\u003e\n\u003cbr\u003eThe Third Annual Retina Festival is an “all-star” line-up of more than 50 faculty members from around the world participating in a Continuing Medical Education event from the Wilmer Eye Institute of the Johns Hopkins University School of Medicine. The program will provide the latest updates from clinical trials and other evidence in the peer-reviewed medical literature that are relevant to the prevention and management of retinal diseases around the world.\u003cbr\u003e\u003cbr\u003eTopics include the latest, clinically relevant outcomes from clinical trials on age-related macular degeneration, vitreomacular interface abnormalities, hereditary retinal degenerations, diabetic retinopathy, retinal vein occlusions, and the latest in retinal surgery, including live retina surgery demonstrations. In addition to presentations from world experts, 4 panels of experts throughout the day will highlight discussions on applying clinical trial results to day-to-day clinical practice. The course should be of interest to comprehensive ophthalmologists, retina specialists both expert and in training, as well as vision scientists who want an update on the latest clinically relevant topics in retina.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eWHO SHOULD ATTEND\u003c\/strong\u003e\u003cbr\u003eThis activity is intended for ophthalmologists, optometrists, and ophthalmic allied health professionals.\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eObjectives\u003c\/strong\u003e\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eRecognize the role of anti-angiogenic treatments for eyes with choroidal neovascularization from age-related macular degeneration or diabetic retinopathy, including proliferative diabetic retinopathy and diabetic macular edema.\u003c\/li\u003e\n\u003cli\u003eEvaluate recent clinical studies evaluating treatments for hereditary retinal degenerations.\u003c\/li\u003e\n\u003cli\u003eDiscuss the role of imaging in the management of vitreomacular interface abnormalities.\u003c\/li\u003e\n\u003cli\u003eReview the current and emerging therapeutic approaches for surgical retinal diseases.\u003c\/li\u003e\n\u003cli\u003eSummarize the evidence of surgical and medical treatments for intraocular tumors.\u003c\/li\u003e\n\u003cli\u003eDetermine which patients are appropriate for biologic treatments of posterior uveitis.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cbr\u003eThe Johns Hopkins Wilmer Eye Institute’s 3rd Annual Retinal Festival (2022) was best for ophthalmologists, retina specialists, fellows, residents, and vision researchers who wanted a fast-paced, evidence-based update on retinal disease management, with insights from global leaders.\u003cbr\u003e\u003ch3\u003e👩‍⚕️ Who Should Attend\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eRetina specialists and ophthalmologists managing patients with macular degeneration, diabetic retinopathy, retinal vein occlusion, and other retinal disorders\u003c\/li\u003e\n\u003cli\u003eResidents and fellows in ophthalmology seeking exposure to high-level case discussions and clinical trial updates\u003c\/li\u003e\n\u003cli\u003eVision scientists and researchers interested in translational applications of new therapies\u003c\/li\u003e\n\u003cli\u003eAllied eye care professionals supporting retinal disease management in clinical practice\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e📚 What You’d Learn\u003c\/h3\u003e\n\u003cbr\u003eThe 2022 festival featured an “all-star” faculty lineup of more than 50 experts worldwide. Key highlights included:\u003cbr\u003e\u003cul class=\"relative list-outside marker:text-foreground-750 dark:marker:text-foreground-600 flex flex-col ms-4 px-1\"\u003e\n\u003cli\u003eLatest updates from clinical trials and peer-reviewed literature relevant to retinal care\u003c\/li\u003e\n\u003cli\u003ePractical strategies for applying new therapies and imaging technologies in patient management\u003c\/li\u003e\n\u003cli\u003eCase-based discussions bridging research findings and real-world practice\u003c\/li\u003e\n\u003cli\u003eNetworking opportunities with Johns Hopkins faculty and international retina leaders\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cstrong\u003eTopics:\u003c\/strong\u003e\n\u003cbr\u003e\u003ch3 class=\"boxAgendaTitle\"\u003eSaturday, December 3, 2022\u003c\/h3\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cdiv class=\"12u\"\u003e\n\u003cdiv class=\"boxAgenda agendaBlue\"\u003e\n\u003cdiv class=\"row 50%\"\u003e\n\u003cul\u003e\n\u003cli class=\"10u\"\u003e7:30AM – 7:45AM Welcome and Conference Goals Neil Bressler, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e7:30AM – 7:40AM Zoom Webinar Link\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e7:35AM – 7:45AM Lessons Learned in Retina Research: From Residency to Retirement Paul Sternberg, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e7:45AM – 7:55AM Emerging Treatments for Stargardt Disease and Current Recommendations for Patient Management Hendrik P Scholl, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e7:45AM – 8:45AM Moderator: Age-related Macular Degeneration – Geographic Atrophy and Their Masquerades Sandrine Zweifel, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e7:45AM – 8:45AM Moderator: Age-related Macular Degeneration – Geographic Atrophy and Their Masquerades Hendrik P Scholl, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e7:55AM – 8:05AM RPE Transplantation Human Subjects Research Amir H Kashani, MD, PhD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e8:05AM – 8:15AM Interpreting Geographic Atrophy Progression in Clinical Trials Maureen G Maguire, PhD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e8:15AM – 8:25AM Clinical Relevance of Recent Geographic Atrophy Clinical Trials Sandrine Zweifel, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e8:45AM – 10:30AM Moderator: Age-related Macular Degeneration – Choroidal Neovascularization J. Fernando Arevalo, MD, PhD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e8:45AM – 10:30AM Moderator: Age-related Macular Degeneration – Choroidal Neovascularization Cindy X Cai, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e8:45AM – 8:55AM Role of Fluorescein, ICG, and OCT Angiography in Neovascular AMD Voraporn Chaikitmongkol, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e8:55AM – 9:05AM Updates on Gene Therapy to Deliver Anti-VEGF Proteins for Retinal and Choroidal Vascular Diseases: Potential Benefits and Risks Peter A Campochiaro, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e9:05AM – 9:15AM Recent Clinical Trials in Uveitis for the Retina Specialist Douglas A Jabs, MD, MBA\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e9:15AM – 9:25AM Potential Advantages and Disadvantages of Slow Release Devices for Neovascular AMD Dante Pieramici, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e9:25AM – 9:35AM Potential Advantages and Disadvantages of Slow Release Devices for Neovascular AMD Gemmy Cheung, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e10:30AM – 10:40AM Epidemic of Pathologic Myopia Caroline Klaver, MD, PhD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e10:30AM – 11:15AM Moderator: Pathologic Myopia: Classification of Common Retinal Diseases Adam S Wenick, MD, PhD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e10:30AM – 11:15AM Moderator: Pathologic Myopia: Classification of Common Retinal Diseases Kyoko Ohno-Matsui, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e10:40AM – 10:50AM Surgical Management of Epiretinal Membranes, Vitreomacular Traction, Macular Holes or Schisis in Pathologic Myopia Taiji Sakamoto, MD, PhD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e10:50AM – 11:00AM Current Classification of Pathologic Myopia Kyoko Ohno-Matsui, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e11:15AM – 11:25AM Choroidal Melanoma Management in 2023 Carol L Shields, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e11:15AM – 12:45PM Moderator: Intraocular Tumors Carol L Shields, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e11:15AM – 12:45PM Moderator: Intraocular Tumors David H Abramson, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e11:25AM – 11:35AM Recent Advances in Management of Retinoblastoma David H Abramson, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e12:45PM – 1:45PM Moderator: Surgical Innovations in Retina Stanislao Rizzo, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e12:45PM – 1:45PM Moderator: Surgical Innovations in Retina Narine Viruni, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e12:45PM – 12:55PM Updates on Voretigene NeparvovecRZYL and Other Agents for Retinal Degenerations William F Mieler, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e12:55PM – 1:05PM 3D Monitors for Retina Surgery Stanislao Rizzo, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e1:05PM – 1:15PM Gene Therapy in Retinal Diseases in 2022 Jacque Duncan, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e1:15PM – 1:25PM Monitoring ROP in 2022 J Peter P Campbell, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e1:45PM – 1:55PM Choosing Agents for Macular Edema from Retina Vein Occlusions Sobha Sivaprasad, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e1:45PM – 3:00PM Moderator: Retinal Vascular Diseases Adrienne Scott, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e1:45PM – 3:00PM Moderator: Retinal Vascular Diseases Sobha Sivaprasad, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e1:55PM – 2:05PM Biosimilars for Retinal Disease Peter K Kaiser, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e2:05PM – 2:15PM Current Management of Sickle Cell Retinopathy Adrienne Scott, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e3:00PM – 3:45PM Moderator: Diabetic Retinopathy Susan Bressler, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e3:00PM – 3:45PM Moderator: Diabetic Retinopathy Jun Kong, MD, PhD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e3:00PM – 3:10PM Step Therapy for DME: Protocol AC Results Chirag Jhaveri, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e3:10PM – 3:20PM From Airlie House to ETDRS to DRCR Retina Network in 2022: Imaging NPDR for Risk Factors to Develop PDR Jennifer Sun, MD, MPH\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e3:20PM – 3:30PM Management of Moderate to Severe NPDR: Results from Protocol W Raj Maturi, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e3:45PM – 3:55PM Home Monitoring in AMD or DR: OCT, Visual Acuity or Both Anat Loewenstein, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e3:45PM – 5:25PM Moderator: Other Hot Topics in Retina Mira Sachdeva, MD, PhD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e3:45PM – 5:25PM Moderator: Other Hot Topics in Retina T. Y. Alvin Liu, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e3:45PM – 5:25PM Moderator: Other Hot Topics in Retina Kapil Mishra, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e3:55PM – 4:05PM Artificial Intelligence in Retina Aaron Lee, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e4:05PM – 4:15PM Diversity, Inclusiveness and Equity in Retina Judy E Kim, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e4:15PM – 4:35PM Faricimab and Other New Anti-VEGF Agents for Neovascular AMD Susan Bressler, MD\u003c\/li\u003e\n\u003cli class=\"10u\"\u003e4:55PM – 5:25PM Summary and Closing Remarks J. Fernando Arevalo, MD, PhD\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"related products\"\u003e\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"related products\"\u003e\u003c\/section\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954505846882,"sku":"MED-AMB04885","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Johns-Hopkins-Wilmer-Eye-Institutes-3rd-Annual-Retinal-Festival-2022.jpg?v=1779378381","url":"https:\/\/meducourse.com\/products\/johns-hopkins-wilmer-eye-institutes-3rd-annual-retinal-festival-2022","provider":"Meducourse","version":"1.0","type":"link"}